Drug Channels

They say you get what you negotiate, not what you deserve. Well, here’s the proof from the cover story in last Thursday’s Wall Street Journa...

Here are a few interesting articles that I come across but don’t have the time or inclination to blog about. Enjoy! As always, I welcome l...

As a follow-up to yesterday's Pfizer Tries to Choke Demand for Parallel Imports , check out NHS Drug Shortage Looms as Pound Falls from...

Mmmmm, rats. They’re not just for breakfast anymore! Pfizer has started a new advertising campaign in the UK that’s designed to ed...

Merck recently announced a new outsourcing deal in which UPS will be taking over Merck’s U.S. distribution operations. See UPS to Manage Mo...

Fair warning: This post will make some people quite uncomfortable. In Who Pays for Prescription Drugs? , I showed you how the payer for pr...

If you’re like me, you spent Sunday afternoon drinking beer, watching the Eagles trounce the Giants (whoo-hooo!), and poring over the latest...

In December, dearly-departed Pharmalot reported on an intriguing new Moody’s report about how credit market conditions could affect drug who...

Happy New Year! I hope you all were able to enjoy some nice downtime with your families. I was once again fortunate enough to be on a beac...

Well, here it is -- my 95 th (and final) post for 2008. Before I wrap up for the year, I want to give you a brief update on Drug Channels...

The European Commission released its “pharmaceutical package” yesterday. As I mentioned in Monday’s post , a strict ban on repackaging of pa...

Drug importation into the U.S. has been declared dead more times than a narcoleptic Jason Voorhees . As a follow-up to Monday's post ab...